5 hrs ago
Harvard Bioscience Reports Second Quarter 2014 Results
In addition to these financial results, we are also encouraged by our bookings and backlog this quarter.
Harvard Bioscience Schedules Second Quarter 2014 Conference Call for July 31, 2014 at 11:00 Am Et
Harvard Bioscience, Inc. , a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, will announce results for its second quarter before market trading hours on Thursday, July 31, 2014.
Zacks Downgrades Harvard Bioscience to Neutral
They currently have a $4.80 price target on the stock. Zacks 's price target indicates a potential upside of 1.91% from the stock's previous close.
Harvard Apparatus Regenerative Technology's HART-Trachea...
Harvard Apparatus Regenerative Technology, Inc. , a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, announces its HART-Trachea was spotlighted in a two-hour-long NBC-TV News Special on Friday, June 27. Titled "A Leap of Faith: A Meredith Vieira Special," the program focuses on the ... (more)
Harvard Bioscience CFO Buys $19,300 in Stock
Harvard Bioscience CFO Robert E. Gagnon acquired 5,000 shares of the company's stock on the open market in a transaction that occurred on Monday, June 16th.